3D Printed Microneedle Patches by DLP Printing

Date & time: 2024-04-25 16:00:00

CEST

Hosted by:

Prof. Dimitrios Lamprou, Queen’s University Belfast

SPEAKER

Prof. Dimitrios Lamprou

Chair of Biofabrication & Advanced Manufacturing

Queen’s University Belfast

25 April
2024
4 p.m. CEST
10 a.m. EDT

Make sure to tune in at the designated time as this webinar will not be available on demand. 

About the webinar

Microneedles (MNs) offer an effective method for enhancing drug penetration into the skin by mechanically disrupting the skin barrier. However, traditional MN preparation methods are time-consuming, requiring special moulds and extensive labour.

Using 3D printing (3DP) can revolutionizes MN production by significantly reducing time and allowing for easy customization of shape and size. Yet, the challenge arises with drug solubility in the printing resin, especially if water is the primary solvent.

In this webinar Professor Lamprou, will provide examples from his research Lab in the manufacturing of 3D printed MNs (e.g., solid, dissolving, and hollow) using the Lumen X bioprinter.

Join us to learn about:

  • 3D printing in the manufacturing of Microneedles.
  • Hollow Microneedle Arrays for drug delivery and diagnostics.
  • Dissolving microneedles on the delivery of APIs.

About the speaker

Professor Dimitrios Lamprou (Ph.D., MBA) is Full Professor (Chair) of Biofabrication and Advanced Manufacturing and Director at MSc Industrial Pharmaceutics at Queen’s University Belfast. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS). 
 
Dimitrios, is the author of over 160 peer-reviewed publications, has over 450 conference abstracts, has given over 170 Invited Talks in institutions and conferences across the world, and has secure Funding in excess of £5.5M.
Dimitrios, has been recognised as world leader in Printing with PubMed-based algorithms placed him in the top 0.1% of scholars in the world writing about Printing, over the last 10 years.
 
Dimitrios, has been named in the Stanford University’s list of World’s Top 2% Scientists, for several consecutive years, for his research in Pharmaceutics and Biomedical Engineering.
 

For more info visit www.emergingtechnologieslab.com.